JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 29 No. 10 1719-1723
© 1988 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strand, S.-E.
Right arrow Articles by Löwenhielm, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strand, S.-E.
Right arrow Articles by Löwenhielm, P.

Thyroid Uptake of Iodine-131 and Iodine-133 from Chernobyl in the Population of Southern Sweden

Sven-Erik Strand, Kjell Erlandsson and Peter Löwenhielm

Departments of Radiation Physics and Forensic Medicine, University of Lund, Sweden

Correspondence: For reprints contact: Sven-Erik Strand, PhD, Radiation Physics Dept., Lasarettet, S-221 85 Lund, Sweden.

ABSTRACT

The accident at the nuclear power plant of Chernobyl on April 26, 1986 led to radioactive contamination of many countries including Sweden. The population was exposed to released radionuclides, both by inhalation and from contaminated food. We have studied the content of gamma-emitting radioisotopes in the thyroid glands of a normal population from southern Sweden using measurements of samples taken at autopsy. The first samples are from a person who died on April 27, 1986. This report contains results for 131I and 133I. The time-activity curve for 131I shows an immediate uptake with a maximum 18–26 days after the accident. No measurable levels were observed after 93 days. We have found that the increase in dose equivalent to the thyroid for the population of southern Sweden due to the released 131I and 133I will be < 0.1 mSv. This may lead to an increase in the incidence of thyroid cancer of 0.1% during a period of 25 yr.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1988 by the Society of Nuclear Medicine.